Provided herein are methods for treating cancer by administering a pharmaceutical composition comprising a fixed, non-antagonistic molar ratio of irinotecan and floxuridine. One method includes: obtaining an interference degree that is caused when a site device performs full-duplex transmission with at least two UEs; and determining, according to the interference degree, a UE allowed to transmit uplink and downlink signals on the same time and frequency resource among the at least two UEs. The second conductive pattern is overlaid the first conductive pattern such that the second land is positioned over the first land. The frame is configured for positioning on a door to facilitate the forming of openings in a door for the installation of a lockset.